Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan

NCT01251835 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Sitaxsentan alone
DRUG: Sitaxsentan
DRUG: Rifampin

Sponsor

Pfizer